200
Participants
Start Date
August 14, 2023
Primary Completion Date
August 1, 2027
Study Completion Date
August 1, 2027
The sampling method selected in patients with suspected hilar cholangiocarcinoma
The appropriate sampling approach was selected as EUS-FNA/B or ERCP with or without POCS-TB based on experts' overall evaluation. This study will compare the histopathological diagnosis of the selected sampling method with the final diagnosis.
RECRUITING
Qilu Hospital of Shandong University, Jinan
First Affiliated Hospital, Sun Yat-Sen University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
LanZhou University
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Beijing Friendship Hospital
OTHER
Third Affiliated Hospital, Sun Yat-Sen University
OTHER
Binzhou Medical University
OTHER
Shandong Provincial Hospital
OTHER_GOV
The Second Hospital of Hebei Medical University
OTHER
Qilu Hospital of Shandong University
OTHER